Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Can't work it out
Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
How does tirzepatide reconstitution compare to semaglutide reconstitution
12 May 2017
US$ 21.12
US$ 27.92
US$ 20.44
US$ 24.56
US$ 25.15
